Stereoisomers of fatty acid analogs for diagnostic imaging

Details Stereoisomers of fatty acid analogs for diagnostic imaging Stereoisomers of fatty acid analogs for diagnostic imaging

2006-02-28

2006-02-28

Page, Thurman K. (Department: 1615)

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

C424S001110

Reexamination Certificate

active

07005119

ABSTRACT:
The present invention provides novel imaging agents for clinical diagnosis of injuries and diseases, in the form of a radionuclide in spatial proximity to a substantially pure stereoisomer of a fatty acid analog. The invention also provides methods for using the novel imaging agents, and kits containing one or more of the novel imaging agents of the invention.

REFERENCES:
patent: 3716631 (1973-02-01), Steggerda et al.
patent: 4323547 (1982-04-01), Knust et al.
patent: 4473544 (1984-09-01), Machulla et al.
patent: 4476106 (1984-10-01), Bardy et al.
patent: 4524059 (1985-06-01), Elmaleh et al.
patent: 4746505 (1988-05-01), Jones et al.
patent: 4764358 (1988-08-01), Knapp, Jr. et al.
patent: 4877599 (1989-10-01), Lees
patent: 5021220 (1991-06-01), Mertens
patent: 5370860 (1994-12-01), Elgavish et al.
patent: 2003/0215386 (2003-11-01), Elmalch
Benjamin F. Cravatt et al., “Chemical Characterization Of A Family Of Brain Lipids That Induce Sleep”,Science, vol. 268: 1506-1509 (1995).
David R. Elmaleh et al., “Corporation of11C and14C-Labeled Fatty Acids And Their β-Methyl Analogs”,Int. J. Nucl. Med. Biol.vol. 10, No. 4: 181-187 (1983).
David R. Elmaleh et al., “Myocardial Extraction of 1-[11C] Betamethylheptadecanoic Acid”,The Journal of Nuclear Medicine, vol. 35, No. 3: 496-503 (1994).
Eli Livni et al., “Beta-methyl[1-11C] heptadecanoic Acid: A New Myocardial Metabolic Tracer For Positron Emission Tomography”,The Journal of Nuclear Medicine, vol. 23, No. 2: 169-175 (1982).
Alan J. Fischman et al., “Myocardial Fatty Acid Imaging: Rationale, Comparison of11C- and123I-Labeled Fatty Acids, and Potential Clinical Utility”,American Journal of Cardiac Imaging, vol. 3, No. 4: 288-296 (1989).
M.M. Goodman et al., “New Myocardial Imaging Agents: Synthesis of 15-(p-Iodophenyl)-3(R,S)-methylpentadecanoic Acid by Decomposition of a 3,3-(1,5-Pentanediyl) triazene Precursor”,The Journal of Organic Chemistry, vol. 49, No. 13: 2322-2325 (1984).
Gerald S. Jones Jr., et al., “Synthesis and Biodistributionof a New99mTechnetium Fatty Acid”,Nuclear Medical Biology, vol. 21, No. 1: 117-123 (1994).
Anna-Lisa Kairento et al., “Comparative Evaluation of [123l]l4-p-Iodophenyl-Beta-Methyltetradecanoic Acid and Thallium-201 in the Detection of Infarcted Areas in the Dog Heart Using SPECT”,Nuclear Medical Biology, vol. 15, No. 3:333-338 (1988).
F.F. (Russ) Knapp, Jr., “Myocardial Metabolism of Radioiodinated BMIPP”,The Journal of Nuclear Medicine, vol. 36, No. 6: 1051-1054 (1995).
D. Douglas Miller et al., “Fatty Acid Analogue Accumulation: A Marker of Myocyte Viability in Ischemic-Reperfused Myocardium”Circulation Research, vol. 63, No. 4: 681-692 (1988).
Kenji Nakai et al., “Serial Course of Left Ventricular Function, Perfusion and Fatty Acid Uptake in the Cardiomyopathic Hamster”,The Journal of Nuclear Medicine, vol. 34, No. 8: 1309-1315 (1993).
Robert D. Okada et al., “Myocardial Kinetics of1231-Labeled-16-Hexadecanoic Acid”,European Journal of Nuclear Medicine, vol. 8: 211-217 (1983).
Takahashi et al.; “Synthesis of 1-11C-Labeled Fatty Acid From [11C]HCN”, Appl. Radiat. Isot. 41(7); 649-654, (1990).
T. Saito et al., “Differentiation of Regional Perfusion And Fatty Acid Uptake In Zones Of Myocardial Injury”,Nuclear Medicine Communications, vol. 12: 663-675 (1991).
T.W. Graham Solomons., “Fatty Acids and Glyceryl Trialkanoates”,Organic Chemistry, Fourth Edition, pp 1039-1043 (1988).
Shigetoshi Wakasugi et al., “Myocardial Utilization And Left Ventricular Function In Adrianmycin Caryomyopathy”,The Journal of Nuclear Medicine, vol. 34, No. 9: 1529-1535 (1993).
Kazutaka Yamamoto et al., “Dual Tracer Autoradiographic Study of β-Methyl-(114C) Heptadecanoic Acid and 15-p-(131l)-Iodophenyl-β-Methylpentadecanoic Acid In Normaotensive and Hypertensive Rats”,The Journal of Nuclear Medicine, vol. 27, No. 7: 1178-1183 (1986).
Yoshiharu Yonekura et al., “Regional Myocardial Substrate Uptake in Hypertensive Rats: A Quantitative Autoradiographic Measurement”,Science, vol. 227: 1494-1496 (1985).
Communal et al.; Can. J. Physiol. Pharmacol., vol. 72:1120-1126, (Oct. 1994).
Mertens et al.; European Journal of Nuclear Medicine, vol. 13(3): 159-160, (1987).
Takeishi et al.; Annals of Nuclear Medicine, 9(3): 125-130, (Aug. 1995).
Naruse et al.; Kakuigaku, 29(1): 77-84 (1992).
Chang et al; “The Effect of Methyl Palmoxirate on Incorporation of [U—14C] Palmitate Into Rat Brain”, Neurochemical Research 19(9): 1217-1223, (1994).
Nariai et al.; “In Vivo Incorporation of[9,10—3H]- Palmitate Into a Rat Metastatic Brain-Tumor Model”, J. Neurosurg. 74: 643-649, (1991).
Caveliers V, Franken PR, Lin Q, Moker FT, Luo H, Knapp FF Jr. “Intra-Individual Comparison of 3(R)-BMIPP and 3(S)-BMIPP Isomers in Humans,” J. Nucl. Med. 39: 1672-1675, 1998.
De Geeter F, Frankin PR, Knapp FF, Bossuyt A. “Relationship between blood flow and fatty acid metabolism in subacute myocardial infartion: a stucy by means of Tc-Sestamibi and I-β-methyl-iodo-phenyl pentadecanoic acid,” Eur. J. Nucl. Med 21: 283-291, 1994.
Franken PR, De Geeter F, Dendale P, Demoor D, Block P, Bossuyt A. “Abnormal Free Fatty Acid Uptake in Subacute Myocardial Infarction After Coronary Thrombolysis: Correlation with Wall Motion and Inotropic Reserve,”.J. Nucl. Med. 35: 1758-1765, 1994.
Gatley SJ, Halama JR, Holden JE, et al, “On the rate-limiting step in myocardial clearance of label from 16-iodohexadecanoic acid,” J. Nucl. Med. 24: P12, 1983 (abstr.).
Goodman et al., “Synthesis and Evaluation of Radioiodinated Terminal p-Iodophenyl-Substituted α- and β-Methyl-Branched Fatty Acids,” J. Med. Chem., 27:390-397 (1984).
Kropp J, Juergens M, Glaenzer K, Leuderitz B, Biersack H-J, Knapp FF Jr., “Evaluation of ischemia and myocardial viability in patients with coronary artery diease (CAD) with iodine-123 labeldd 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP),” BMIPP. Ann Nucl Med 7: 93-100, 1993.
Lin Q, Luo H, Mokler F, Beets AJ, Ambrose KR, McPherson DW, Kropp J, Knapp FF Jr., “Effects of Configuration on the Myocardial Uptake of Radioiodinated 3(R)-BMIPP and 3(S)-BMIPP in Rats,” J Nucl. Med. 38:1434-1440, 1997.
Machulla HJ, Stocklin G, Kupfernagel C, et al, “Comparative Evaluation of Fatty Acids Labeled with C-11, C1-34m, Br-77 and I-123 for Metabolic Studies of the Myocardium: Concise Communication,” J. Nucl. Med. 19:298-302, 1978.
Most A.S., Brachfeld N, Gorlin R, et al, “Free Fatty Acid Metabolism of the Human Heart at Rest,” J. Clin. Invest. 48:1177-1188, 1969.
Neely, JR, Rovetto MJ, Gram JF: Myocardial Utilization of Carbohydrates and Lipids, Progr. Cardiovasc. Res. 15:289-329, 1972.
Neely JR, Morgan HE, “Relationship Between Carbohydrate and Lipid Metabolism and the Energy Balance of Heart Muscle,” Ann. Rev. Physiol. 36: 413-459, 1974.
Opie LM, “Metabolism of the heart in health and disease,” Am. Heart J. 76: 685-698, 1968.
Poe ND, Robinson GD Jr., MacDonald NS, “Myocardial Extraction of Labeled Long-Chain Fatty Acid Analogs,” Proc. Soc. Exp. Biol. Med 148:215-218, 1975.
Schon HR, Schelbert HR, Robinson G, et al, “C-11 palmitic acid for the noninvasive evaluation of regional fatty acid metabolism with positron-computed tomography,” Am. Heart J. 103: 532-561, 1982.
Schon HR, Senekowitsch R, Berg D, et al, “Measurement of Myocardial Fatty Acid Metabolism: Kinetics of Iodine-123 Heptadecanoic Acid in Normal Dog hearts,” J. Nucl. Med. 27: 1449-1455, 1986.
Zierler KL, “Fatty Acids as Substrates for Heart and Skeletal Muscle,” Circ. Res. 38: 459-463, 1976.
Q. Lin et al., “Effects of Configuration on the Myocardial Uptake of Radioiodinated 3(R)-BM

Affiliated with

Also associated with

Rating

Stereoisomers of fatty acid analogs for diagnostic imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stereoisomers of fatty acid analogs for diagnostic imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stereoisomers of fatty acid analogs for diagnostic imaging will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3627869